Literature DB >> 12402320

Process control for enhanced L-phenylalanine production using different recombinant Escherichia coli strains.

M Gerigk1, R Bujnicki, E Ganpo-Nkwenkwa, J Bongaerts, G Sprenger, R Takors.   

Abstract

A novel fed-batch approach for the production of L-phenylalanine (L-Phe) with recombinant E. coli is presented concerning the on-line control of the key fermentation parameters glucose and tyrosine. Two different production strains possessing either the tyrosine feedback resistant aroF(fbr) (encoding tyrosine feedback resistant DAHP-synthase (3-desoxy-D-arabino-heptusonate-7-phosphate)) or the wild-type aroF(wt) were used as model systems to elucidate the necessity of finding an individual process optimum for each genotype. With the aid of tyrosine control, wild-type aroF(wt) could be used for L-Phe production achieving higher final L-Phe titers (34 g/L) than the aroF(fbr) strain (28 g/L) and providing higher DAHP-synthase activities. With on-line glucose control, an optimum glucose concentration of 5 g/L could be identified that allowed a sufficient carbon supply for L-Phe production while at the same time an overflow metabolism leading to acetate by-product formation was avoided. The process approach is suitable for other production strains not only in lab-scale but also in pilot-scale bioreactors. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402320     DOI: 10.1002/bit.10428

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  9 in total

Review 1.  Metabolic engineering for the production of l-phenylalanine in Escherichia coli.

Authors:  Xiaozhen Liu; Hao Niu; Qiang Li; Pengfei Gu
Journal:  3 Biotech       Date:  2019-02-15       Impact factor: 2.406

2.  Enhanced L-phenylalanine production by recombinant Escherichia coli BR-42 (pAP-B03) resistant to bacteriophage BP-1 via a two-stage feeding approach.

Authors:  Haiyan Zhou; Xianyan Liao; Long Liu; Tianwen Wang; Guocheng Du; Jian Chen
Journal:  J Ind Microbiol Biotechnol       Date:  2010-11-21       Impact factor: 3.346

3.  Metabolic engineering of Escherichia coli for the production of L-valine based on transcriptome analysis and in silico gene knockout simulation.

Authors:  Jin Hwan Park; Kwang Ho Lee; Tae Yong Kim; Sang Yup Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

4.  Bacterial fermentation platform for producing artificial aromatic amines.

Authors:  Shunsuke Masuo; Shengmin Zhou; Tatsuo Kaneko; Naoki Takaya
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

5.  Improving the Production of L-Phenylalanine by Identifying Key Enzymes Through Multi-Enzyme Reaction System in Vitro.

Authors:  Dongqin Ding; Yongfei Liu; Yiran Xu; Ping Zheng; Haixing Li; Dawei Zhang; Jibin Sun
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

6.  In silico functional annotation of hypothetical proteins from the Bacillus paralicheniformis strain Bac84 reveals proteins with biotechnological potentials and adaptational functions to extreme environments.

Authors:  Md Atikur Rahman; Uzma Habiba Heme; Md Anowar Khasru Parvez
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

7.  Improvement of L-phenylalanine production from glycerol by recombinant Escherichia coli strains: the role of extra copies of glpK, glpX, and tktA genes.

Authors:  Katrin Gottlieb; Christoph Albermann; Georg A Sprenger
Journal:  Microb Cell Fact       Date:  2014-07-11       Impact factor: 5.328

8.  A systematic optimization of styrene biosynthesis in Escherichia coli BL21(DE3).

Authors:  Changqing Liu; Xiao Men; Hailin Chen; Meijie Li; Zhaorui Ding; Guoqiang Chen; Fan Wang; Haobao Liu; Qian Wang; Youshuang Zhu; Haibo Zhang; Mo Xian
Journal:  Biotechnol Biofuels       Date:  2018-01-25       Impact factor: 6.040

Review 9.  Unconventional Treatments for Vitiligo: Are They (Un) Satisfactory?

Authors:  Serena Gianfaldoni; Georgi Tchernev; Jacopo Lotti; Uwe Wollina; Francesca Satolli; Miriam Rovesti; Katlein França; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2018-01-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.